Serologic Evidence of Herpes Simplex Virus 1 Infection and Oropharyngeal Cancer Risk
May 29th, 2008 by admin
Jacqueline R. Starr2, Janet R. Daling, E. Dawn Fitzgibbons, Margaret M. Madeleine, Rhoda Ashley, Denise A. Galloway and Stephen M. Schwartz
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98195 [J. R. S., J. R. D., M. M. M., S. M. S.]; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 [J. R. D., E. D. F., M. M. M., S. M. S.]; Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle, WA 98195 [R. A.]; Program in Cancer Biology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 [D. A. G.]; Department of Microbiology, School of Medicine, University of Washington, Seattle, WA 98195 [D. A. G.]
In vitro and animal models suggest that the herpes simplex virus 1 (HSV1) may contribute to the development of oropharyngeal squamous cell carcinoma (OSCC). To determine whether the risk of OSCC is related to infection with HSV1 in humans, we recruited 260 patients from 18 to 65 years old who were newly diagnosed with OSCC between 1990–1995 while residing in three western
Posted in Serologic Evidence of Herpes Simplex Virus 1 Infection | No Comments »